In this episode of the pharmaphorum podcast, host Jonah Comstock welcomes Marc de Garidel, CEO of CinCor Pharma, which was just recently sold to AstraZeneca for more than $1 billion USD. Marc tells Jonah all about CinCor and its unique approach to hypertension, how the AstraZeneca deal came about, and what happens next.
03/10/23 • 28 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/pharmaphorum-podcast-382742/cincor-pharma-a-small-pharmas-journey-to-acquisition-54571446"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to cincor pharma: a small pharma’s journey to acquisition on goodpods" style="width: 225px" /> </a>
Copy